Effects of the increase in neuronal fatty acids availability on food intake and satiety in mice

Psychopharmacology

Volumn 210, Issue 1, 2010, Pages 85-95

  Coccurello, Roberto ^a   Caprioli, Antonio ^b   Bellantuono, Sara ^a   D'Amato, Francesca R ^a   Conti, Roberto ^b   Giannessi, Fabio ^b   Borsini, Franco ^b   Moles, Anna ^a  

^a CNR   (Italy)

^b Sigma Tau SpA   (Italy)

Author keywords

Behavioral satiety sequence; Carnitine palmitoyltransferase 1; Free fatty acids; Nutrients sensing; Satiety

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE I; ENZYME INHIBITOR; FATTY ACID; OLEIC ACID; ST 1326; ST 1340; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOREXIA; ARTICLE; BRAIN LEVEL; BRAIN TISSUE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; FEEDING BEHAVIOR; FOOD INTAKE; HABITUATION; MALE; MOUSE; NONHUMAN; NUTRIENT AVAILABILITY; PALATABILITY; PRIORITY JOURNAL; REST; SATIETY;

ANIMALS; EATING; FATTY ACIDS, NONESTERIFIED; FEEDING BEHAVIOR; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; NEURONS; SATIETY RESPONSE;

EID: 77955568485     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-010-1820-0     Document Type: Article

References (37)

1. Antin J, Gibbs J, Holt J, Young RC, Smith GP (1975) Cholecystokinin elicits the complete behavioral sequence of satiety in rats. J Comp Physiol Psychol 89:784-790
2. Bays HE (2004) Current and investigational antiobesity agents and obesity therapeutic treatment targets. Obes Res 12:1197-1211
3. Blundell JE, Latham CJ (1979) Serotonergic influences on food intake: effect of 5-HT on parameters of feeding behaviour in deprived and free-feeding rats. Pharmacol Biochem Behav 11:431-437
4. Blundell JE, Latham CJ, Leshem MB (1976) Differences between the anorexic actions of amphetamine and fenfluramine-possible effects on hunger and satiety. J Pharm Pharmacol 28:471-477
5. Chen N, Appell M, Berfield JL, Reith ME (2003) Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter. Eur J Pharmacol 478:89-95
6. Clifton PG (2000) Meal patterning in rodents: psychopharmacological and neuroanatomical studies. Neurosci Biobehav Rev 24:213-222
7. Dalton GL, Lee MD, Kennett GA, Dourish CT, Clifton PG (2006) Serotonin 1B and 2C receptor interactions in the modulation of feeding behaviour in the mouse. Psychopharmacology 185:45-57
8. Dourish CT, Rycroft W, Iverson SD (1989) Postponement of satiety by blockage of brain Cholecystokinin (CCK-B) receptors. Science 245:1509-1511
9. Florentin M, Liberopoulos EN, Elisaf MS (2008) Sibutramineassociated adverse effects: a practical guide for its safe use. Obes Rev 9:378-387
10. Franklin BJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic, San Diego
11. Giannessi F, Pessotto P, Tassoni E, Chiodi P, Conti R, De Angelis F, Dell'Uomo N, Catini R, Deias R, Tinti MO, Carminati P, Arduini A (2003) Discovery of a long-chain carbamoyl aminocarnitine derivative, a reversible carnitine palmitoyltransferase inhibitor with antiketotic and antidiabetic activity. J Med Chem 46:303-309
12. Halford JC, Wanninayake SC, Blundell JE (1998) Behavioral satiety sequence (BSS) for the diagnosis of drug action on food intake. Pharmacol Biochem Behav 61:159-168
13. Heller A, Won L, Bubula N, Hessefort S, Kurutz JW, Reddy GA, Gross M (2005) Long-chain fatty acids increase cellular dopamine in an immortalized cell line (MN9D) derived from mouse mesencephalon. Neurosci Lett 376:35-39
14. Hewitt KN, Lee MD, Dourish CT, Clifton PG (2002) Serotonin 2C receptor agonists and the behavioural satiety sequence in mice. Pharmacol Biochem Behav 71:691-700
15. Ishii Y, Blundell JE, Halford JC, Rodgers RJ (2003) Palatability, food intake and the behavioural satiety sequence in male rats. Physiol Behav 80:37-47
16. Ishii Y, Blundell JE, Halford JC, Upton N, Porter R, Johns A, Jeffrey P, Summerfield S, Rodgers RJ (2005) Anorexia and weight loss in male rats 24 h following single dose treatment with orexin-1 receptor antagonist SB-334867. Behav Brain Res 157:331-341
17. Kitchener SJ, Dourish CT (1994) An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats. Psychopharmacology 113:369-377
18. Koob GF (1996) Hedonic valence, dopamine and motivation. Mol Psychiatry 1:186-189
19. Kumar MV, Shimokawa T, Nagy TR, Lane MD (2002) Differential effects of a centrally acting fatty acid synthase inhibitor in lean and obese mice. Proc Natl Acad Sci USA 99:1921-1925
20. L'hirondel M, Chéramy A, Godeheu G, Glowinski J (1995) Effects of arachidonic acid on dopamine synthesis, spontaneous release and uptake in striatal synaptosomes from the rat. J Neurochem 64:1406-1409
21. L'hirondel M, Chéramy A, Artaud F, Godeheu G, Glowinski J (1999) Contribution of endogenously formed arachidonic acid in the presynaptic facilitatory effects of NMDA and carbachol on dopamine release in the mouse striatum. Eur J NeuroSci 11:1292-1300
22. Li M, Cheung BM (2009) Pharmacotherapy for obesity. Br J Clin Pharmacol 68:804-810
23. Loftus TM, Jaworsky DE, Frehywot GL, Townsend CA, Ronnett GV, Lane MD, Kuhajda FP (2000) Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288:2379-2381
24. López-Alonso VE, Mancilla-Díaz JM, Rito-Domingo M, González-Hernández B, Escartín-Pérez RE (2007) The effects of 5-HT1A and 5-HT2C receptor agonists on behavioral satiety sequence in rats. Neurosci Lett 416:285-288
25. Obici S, Feng Z, Morgan K, Stein D, Karkanias G, Rossetti L (2002) Central administration of oleic acid inhibits glucose production and food intake. Diabetes 51:271-275
26. Obici S, Feng Z, Arduini A, Conti R, Rossetti L (2003) Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat Med 9:645-647
27. Padwal RS, Majumdar SR (2007) Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 369:71-77
28. Padwal RS, Rucker D, Li SK, Curioni C, Lau DCW (2004) Long-term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev 4: CD004094
29. Pitha J, Gerloczy A, Olivi A (1994) Parenteral hydroxypropyl cyclodextrins: intravenous and intracerebral administration of lipophiles. J Pharm Sci 83:833-837
30. Pocai A, Lam TK, Obici S, Gutierrez-Juarez R, Muse ED, Arduini A, Rossetti L (2006) Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats. J Clin Invest 116:1081-1091
31. Rodgers RJ, Halford JC, Nunes de Souza RL, Canto de Souza AL, Piper DC, Arch JR, Upton N, Porter RA, Johns A, Blundell JE (2001) SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur J NeuroSci 13:1444-1452
32. Simansky KJ, Vaidya AH (1990) Behavioral mechanisms for the anorectic action of the serotonin (5-HT) uptake inhibitor sertraline in rats: comparison with directly acting 5-HT agonists. Brain Res Bull 25:953-960
33. Vögler O, López-Bellan A, Alemany R, Tofé S, González M, Quevedo J, Pereg V, Barceló F, Escriba PV (2008) Structureeffect relation of C18 long-chain fatty acids in the reduction of body weight in rats. Int J Obes 32:464-473
34. Wang R, Cruciani-Guglielmacci C, Migrenne S, Magnan C, Cotero VE, Routh VH (2006) Effects of oleic acid on distinct populations of neurons in the hypothalamic arcuate nucleus are dependent on extracellular glucose levels. J Neurophysiol 95:1491-1498
35. Willner P, McGuirk J, Phillips G, Muscat R (1990) Behavioural analysis of the anorectic effects of fluoxetine and fenfluramine. Psychopharmacology 102:273-277
36. Yaksh TL, Jang JD, Nishiuchi Y, Braun KP, Ro SG, Good man M (1991) The utility of 2-hydroxypropyl-beta-cyclodextrin as a vehicle for the intracerebral and intrathecal administration of drugs. Life Sci 48:623-633
37. Zhang L, Reith ME (1996) Regulation of the functional activity of the human dopamine transporter by the arachidonic acid pathway. Eur J Pharmacol 315:345-354